Why the study?
Despite significant national declines in ischemic heart disease mortality, geographic disparities persist that may, in part, be attributed to environmental effects.
Is ambient PM2.5 exposure associated with ischemic heart disease mortality in California's Central Valley?
Is ambient PM2.5 exposure associated with ischemic heart disease mortality in California's Central Valley?
Environmental exposure to PM2.5 is significantly correlated with geographic disparities in ischemic heart disease mortality, highlighting the need for environmental policy alongside traditional risk factor management.
Answers are grounded in this paper and cite their sources.
Persistent north-south IHD mortality gradient correlates with PM2.5; leaves open environmental contributions to disparities pending prospective data.
Background Nationally, ischemic heart disease mortality has declined significantly due to advancements in managing traditional risk factors of hypertension, diabetes, hyperlipidemia, smoking, and obesity and acute intervention. However geographic disparities persist that may, in part, be attributed to environmental effects. Methods Ischemic heart disease age-adjusted mortality were obtained from the CDC database for years 1999 through 2014 by county, gender, race, and Hispanic origin for the Central Valley of California. Results There was an increase in mortality from north to south of 14.9 (95% CI: 8.0–21.9, p value <0.0001) in time period 1, 7.9 (95% CI: 0.8–15, p value <0.05) in time period 2, and 9.2 (95% CI: 4.0–14.3, p value <0.001) in time period 3. In time period 1, the ambient particulate matter ≤2.5 micrometers (PM 2.5 ) level increased from north to south by 0.84 µg/m³ (95% CI: 0.71–0.96), in time period 2 there was a 0.87 µg/m³ increase (95% CI: 0.74–1.0), and a 1.0 µg/m³ increase in time period 3 (95% CI: 0.87–1.1). PM 2.5 level was correlated to IHD mortality in all time periods (Period 1 r 2 = 0.46, p = 0.0001; Period 2, r 2 = 0.34, p = 0.008; Period 3 r 2 = 0.51, p value <0.0001). Conclusion Continued declines in ischemic heart disease mortality will depend on the concerted efforts of clinicians in continuing management of the traditional risk factors with appropriate medication use, acute interventions for coronary syndromes, the necessity of patient self-management of high risk behaviors associated with smoking and obesity, and the development of coordinated actions with policy makers to reduce environmental exposure in their respective communities.
No takes yet. Share an insight, caveat, or question.
Spada et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: